Back to search

Article

Impact of LP.8.1-Adapted mRNA Vaccination on SARS-CoV-2 Variant Neutralisation

2025-10-23

Abstract excerpt

SARS-CoV-2 continues to evolve, with successive variants evading immunity established through prior infection or vaccination. By mid-2025, the XFG lineage emerged and began replacing LP.8.1 across multiple geographical regions, indicating further adaptive evolution within the JN.1-derived clade. We therefore assessed immune responses in 42 healthcare workers who received 30 μg of LP.8.1-adapted mRNA vaccine (Comir...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c4720fb0-282c-59e2-911b-5837831cda9d
DOI
10.1101/2025.10.21.25338461
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Impact of LP.8.1-Adapted mRNA Vaccination on SARS-CoV-2 Variant NeutralisationDOI 10.1101/2025.10.21.25338461
Antibody responses to SARS-CoV-2 variants LP.8.1, LF.7.1, NB.1.8.1, XFG and BA.3.2 following KP.2 monovalent mRNA vaccinationSemantic proximity
Optimised Non-Coding Regions of mRNA SARS-CoV-2 Vaccine CV2CoV Improves Homologous and Heterologous Neutralising Antibody ResponsesSemantic proximity
Immunogenicity and safety of LP.8.1 variant-containing mRNA COVID-19 vaccinesSemantic proximity
Immunological imprinting shapes the cross-reactive antibody responses to the KP.2 and LP.8.1 vaccine dosesSemantic proximity
SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines.Semantic proximity
Immunogenicity and Reactogenicity of a First Booster with NT162b2or Full-Dose mRNA-1273: A Randomised VACCELERATE Trial in Adults ≥75 Years (EU-COVAT-1)Semantic proximity
mRNA vaccination compared to infection elicits an IgG-predominant response with greater SARS-CoV-2 specificity and similar decrease in variant spike recognitionSemantic proximity
SARS-CoV-2 B.1.1.7 sensitivity to mRNA vaccine-elicited, convalescent and monoclonal antibodiesSemantic proximity
Sub-optimal Neutralisation of Omicron (B.1.1.529) Variant by Antibodies induced by Vaccine alone or SARS-CoV-2 Infection plus Vaccine (Hybrid Immunity) post 6-monthsSemantic proximity
Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5Semantic proximity
SARS-CoV-2 Infections in mRNA Vaccinated Individuals are Biased for Viruses Encoding Spike E484K and Associated with Reduced Infectious Virus Loads that Correlate with Respiratory Antiviral IgG levelsSemantic proximity
Determinants of early antibody responses to COVID-19 mRNA vaccines in exposed and naive healthcare workersSemantic proximity
Select a neighboring publication to make it the new centre.